GovWire

Women's health tech firm attracts £4.8 million investment

Innovate UK

March 29
09:30 2017

A funding round by fem-tech business Chiaro has attracted 4.8 million of external investment. This is to support the development of 3 more smart products addressing female health and wellbeing and help it expand into 25 countries.

Joining the round are Octopus Ventures, a leading tech investor and Allbright, a venture capital fund that invests in female entrepreneurs, amongst others. It brings Chiaros total capital to 9.6 million.

Innovate UK awarded Chiaro a grant in its start-up phase, as it sought to leverage the latest developments in wearable technology and create a connected pelvic floor exercise tool, Elvie.

Exciting moment for tech for women

Tania Boler, CEO and Co-founder, said:

Women and consumer tech have never been a very exciting space for investors. Theres been an assumption that women arent early adopters of tech, which were trying to prove isnt correct.

Now is an exciting moment for tech for women. Theres a big feminist movement and a paradigm shift in technology and health.

Take a peek inside the Chiaro office.

Elvie is a kegel exercise tracker for the pelvic floor. Weakened pelvic floor muscles can cause more than half of all womens bladder, sex or prolapse problems. Women can use their smartphones to find out how to strengthen their muscles and monitor progress.

Within 6 months of the device going on sale Chiaro was making a profit. Last year the company reported direct sales of 800,000. It has recently struck deals with major retailers including John Lewis and Amazon.

Most promising startups

Chiaro is part of Tech City UKs Upscale programme of 33 most promising startups. It has also received celebrity attention, with its product having featured on Gwyneth Paltrows Goop website and been included in high-profile gift bags at the Academy Awards.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: